Holen Sie sich die Stockscreener-App
1.33
8.90%
-0.13
Handel nachbörslich:
1.30
-0.03
-2.26%
Schlusskurs vom Vortag:
$1.46
Offen:
$1.39
24-Stunden-Volumen:
1.74M
Relative Volume:
0.12
Marktkapitalisierung:
$226.96M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-63.55M
KGV:
-
EPS:
-
Netto-Cashflow:
$-9.56M
1W Leistung:
-4.32%
1M Leistung:
-22.67%
6M Leistung:
+62.20%
1J Leistung:
+0.00%
1-Tages-Spanne:
$1.32
$1.45
1-Wochen-Bereich:
$1.32
$1.91
52-Wochen-Spanne:
$0.2556
$9.51
Tevogen Bio Holdings Inc Stock (TVGN) Company Profile
Firmenname
Tevogen Bio Holdings Inc
Sektor
Branche
Telefon
646-807-8832
Adresse
15 INDEPENDENCE BOULEVARD, SUITE 410, WARREN
Vergleichen Sie TVGN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| TVGN | 1.33 | 226.96M | 0 | -63.55M | -9.56M | 0.00 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Tevogen Bio Holdings Inc Aktie (TVGN) Neueste Nachrichten
UPDATETevogen Founder Reflects on Importance of - GlobeNewswire
Tevogen Founder Reflects on Importance of Preserving - GlobeNewswire
Tevogen Bio Achieves $40M Cost Efficiency While Building Biotech Portfolio | TVGN Stock News - StockTitan
Tevogen Bio Shares Are On The Rise Monday: What's Going On? - Benzinga
Tevogen Bio Partners with Microsoft Corporation (MSFT) to Leverage Advanced AI Tools for Biotech Research in Healthcare - Yahoo Finance
Tevogen Bio Nears Finalization of Agreement to Enhance R&D and Manufacturing Capabilities; $36 Million Line of Credit Available for Continued Operations - The Manila Times
Tevogen Bio Nears Finalization of Agreement to Enhance R&D - GlobeNewswire
Tevogen Bio Secures $36M Credit Line, Expands Manufacturing With Strategic Deal | TVGNW Stock News - StockTitan
Tevogen Bio partners Microsoft for HPV treatment - Yahoo! Voices
Tevogen Bio Holdings Inc (TVGN-Q) QuotePress Release - The Globe and Mail
Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company's Novel Business Model as Key to Sustainable Success through Patient Affordability - The Manila Times
Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigio - WICZ
Tevogen Bio CEO Dr. Ryan Saadi Expresses Gratitude for Prestigious ROI-NJ Recognition, Highlighting Company’s Novel Business Model as Key to Sustainable Success through Patient Affordability - GlobeNewswire
TVGNTevogen Bio Holdings Inc. Latest Stock News & Market Updates - StockTitan
Tevogen Bio Leverages Microsoft Partnership to Deliver Machine Learning Based Target Identification to Address Human Papilloma Virus (HPV), Advancing TVGN 920 - The Manila Times
Tevogen Bio advances HPV oncology treatment TVGN 920 By Investing.com - Investing.com UK
Tevogen Bio Leverages Microsoft Partnership to Deliver Machine L - WICZ
Tevogen Bio Teams with Microsoft AI to Fast-Track HPV Cancer Treatment Development | TVGN Stock News - StockTitan
Tevogen Bio Announces Appointment of Anthony Tarantino as - GlobeNewswire
Tevogen Bio Announces Appointment of Anthony Tarantino as Patient Advocate to Enhance Community Engagement and Patient Support - Yahoo Finance
Tevogen Bio Holdings Inc. Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs - Marketscreener.com
Tevogen partners with Microsoft to speed up drug development By Investing.com - Investing.com Australia
Tevogen Bio Expands on Microsoft Partnership to Integrate Machine Learning and AI into Preclinical Processes, Accelerating Drug Development and Reducing Costs - The Manila Times
Tevogen Bio Expands on Microsoft Partnership to Integrate - GlobeNewswire
Tevogen Bio Reports Nasdaq Listing Compliance as CEO Reaffirms His Commitment in Bridging the Information Gap About the Company - The Manila Times
Tevogen Bio Reports Nasdaq Listing Compliance as CEO - GlobeNewswire
Tevogen Bio Signs Letter of Intent With CD8 Technology to - GlobeNewswire
Tevogen Bio plans new R&D and manufacturing facility By Investing.com - Investing.com UK
Tevogen Bio Signs Letter of Intent With CD8 Technology to Build Up to a $50 Million R&D and Manufacturing Facility; No Impact on Shareholder Equity - StockTitan
Philips Posts Weak Earnings, Joins Clear Channel Outdoor And Other Big Stocks Moving Lower In Monday's Pre-Market SessionKoninklijke Philips (NYSE:PHG) - Benzinga
Tevogen Bio Provides Additional Guidance on Introduction of T Cell Therapy for Oncology and Specialty Care Therapeutic Areas - ForexTV.com
Tevogen Bio Provides Additional Guidance on Introduction of - GlobeNewswire
Tevogen Bio (NASDAQ:TVGN) Shares Gap DownShould You Sell? - MarketBeat
Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Short Interest Up 450.9% in October - MarketBeat
Capri, Coursera, DexCom And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Tevogen Bio Shares Are Soaring Wednesday: What's Going On? - MSN
Tevogen Bio (TVGN) Sees Major Stock Surge After Key AI Move - Stocks Telegraph
Tevogen Bio's Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development - The Manila Times
Tevogen Bio’s Effort in Artificial Intelligence, Tevogen - GlobeNewswire
Tevogen Bio’s Effort in Artificial Intelligence, Tevogen AI, Joins Microsoft for Startups, Begins Accelerating drug Development - StockTitan
Tevogen Bio To Provide Timelines Associated with Recently - GlobeNewswire
Tevogen Bio To Provide Timelines Associated with Recently Announced Revenue Forecast and Updates on Operational Readiness This Week - GlobeNewswire Inc.
Tevogen Bio Provides Clarity on CSO Share Sales to Satisfy - GlobeNewswire
Tevogen Bio Specialty Care Reports Top-Line Revenue Forecast of Nearly $1 Billion in Launch Year and Cumulative 5-Year Estimate Between $18 Billion and $22 Billion - The Manila Times
Tevogen Bio Specialty Care Reports Top-Line Revenue - GlobeNewswire
Tevogen Bio Provides Clarity on CSO Share Sales to Satisfy Tax Obligations, Expects Additional Forecast and Progress Updates in the Coming Days - StockTitan
Teucrium Wheat (WEAT-A) QuotePress Release - The Globe and Mail
Insider Selling: Tevogen Bio Holdings Inc. (NASDAQ:TVGN) Insider Sells 1,078,600 Shares of Stock - MarketBeat
20% Of This Tevogen Bio Holdings Insider's Holdings Were Sold - Simply Wall St
Tevogen says CSO share sale ‘solely’ to satisfy payment of tax obligations - TipRanks
Tevogen bio holdings chief scientific officer sells shares worth $1.75 million - Investing.com UK
Finanzdaten der Tevogen Bio Holdings Inc-Aktie (TVGN)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):